Prognostic relevance of cytogenetic subgroups in 357 patients with myelodysplastic syndromes.

被引：0

作者：

Haase, D ^{[1
]}

Schanz, J ^{[1
]}

Wulich, J ^{[1
]}

Schoch, C ^{[1
]}

Freund, M ^{[1
]}

Haferlach, T ^{[1
]}

Wormann, B ^{[1
]}

Staib, P ^{[1
]}

Lentini, G ^{[1
]}

Bartels, H ^{[1
]}

Geissler, RG ^{[1
]}

Germing, U ^{[1
]}

Dorges, U ^{[1
]}

Fonatsch, C ^{[1
]}

Hiddemann, W ^{[1
]}

机构：

[1] UNIV GOTTINGEN,DEPT HEMATOL ONCOL,D-37075 GOTTINGEN,GERMANY

来源：

BLOOD | 1997年 / 90卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2232 / 2232

页数：1

共 50 条

[31] Does cytogenetic evolution have any prognostic relevance in myelodysplastic syndromes? A study on 153 patients from a single institution
Bernasconi, Paolo
Klersy, Catherine
Boni, Marina
Cavigliano, Paola Maria
Giardini, Ilaria
Rocca, Barbara
Zappatore, Rita
Dambruoso, Irene
Calvello, Celeste
Caresana, Marilena
Lazzarino, Mario
ANNALS OF HEMATOLOGY, 2010, 89 (06) : 545 - 551
[32] IDENTIFICATION OF PROGNOSTIC SUBGROUPS BY FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES
van de Loosdrecht, A. A.
Alhan, C.
Cali, C.
Draeger, A. M.
Ossenkoppele, G. J.
Westers, T. M.
CYTOMETRY PART B-CLINICAL CYTOMETRY, 2008, 74B (06) : 395 - 395
[33] IDENTIFICATION OF PROGNOSTIC SUBGROUPS BY FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES
van de Loosdrecht, Arjan
Canan, Alhan
Ossenkoppele, Gert
Westers, Theresia
CYTOMETRY PART B-CLINICAL CYTOMETRY, 2009, 76B (06) : 416 - 416
[34] Biologic and clinical relevance of cytogenetic analysis in primary myelodysplastic syndromes
Raynaud, SD
PATHOLOGIE BIOLOGIE, 2003, 51 (06): : 346 - 355
[35] Cytogenetic and morphologic subgroups of myelodysplastic syndromes in relation to occupational and hobby exposures
Albin, M
Björk, J
Welinder, H
Tinnerberg, H
Mauritzson, N
Billström, R
Strömberg, U
Mikoczy, Z
Johansson, B
Ahlgren, T
Nilsson, PG
Mitelman, F
Hagmar, L
SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH, 2003, 29 (05) : 378 - 387
[36] Sequential cytogenetic analysis of 322 patients with myelodysplastic syndromes.: Delineation of genetic evolution and clinical implications.
Steidl, C
Schabla, R
Germing, U
Hildebrandt, B
Noesslinger, T
Pfeilstocker, M
Haas, P
Lübbert, M
Truemper, LH
Haase, D
BLOOD, 2004, 104 (11) : 651A - 651A
[37] Mitochondrial dysfunction in myelodysplastic syndromes.
Reddy, PL
Dar, S
Anthwal, S
Khan, M
Patkar, K
Rizvi, A
Khan, T
Azhar, O
Nisar, D
Shetty, VT
Mundle, SD
Alvi, S
Galili, N
Raza, A
BLOOD, 2002, 100 (11) : 337B - 337B
[38] Telomere length in myelodysplastic syndromes.
Boultwood, J
Fidler, C
Wainscoat, JS
BLOOD, 1995, 86 (10) : 1325 - 1325
[39] Etiologic factors of myelodysplastic syndromes.
Nisse, C
PATHOLOGIE BIOLOGIE, 1997, 45 (07): : 539 - 544
[40] Mechanisms of Disease: Myelodysplastic Syndromes.
Tefferi, Ayalew
Vardiman, James W.
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (19) : 1872 - 1885

← 1 2 3 4 5 →